# A Research Study of the Effect of Food on Etavopivat in Healthy Participants

> **NCT06433661** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 16 (actual)

## Conditions studied

- Healthy Volunteers Sickle Cell Disease, Thalassemia

## Interventions

- **DRUG:** Etavopivat

## Key facts

- **NCT ID:** NCT06433661
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-28
- **Primary completion:** 2024-07-06
- **Final completion:** 2024-07-08
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06433661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06433661, "A Research Study of the Effect of Food on Etavopivat in Healthy Participants". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT06433661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*